Home Theranica

Theranica

Remote Electrical Neuromodulation as First-Line Treatment for Acute Migraine Relief Shows Promise

The article Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine, reviews a pilot study and a pivotal study conducted to determine the safety and efficacy of the Nerivio™, Theranica's smartphone-connected prescription migraine wearable device. Both studies showed positive results, demonstrating REN is as effective a treatment for acute treatment of migraine as standard pharmacological treatments, with a favorable safety profile.

Theranica Raises $35M to Bring Innovative Migraine Device to the USA

3/18/19: Nerivio Migra®, the company's novel remote neuromodulation device for acute treatment of migraine, is currently under review of the FDA.